ifetroban ifetroban ifetroban is a potent and selective thromboxane receptor antagonist. it has been studied in animal models for the treatment of cancer metastasis, myocardial ischemia, hypertension, stroke, thrombosis, cardiomyopathy, and for its effects on platelets. clinical trials are evaluating the therapeutic safety and efficacy of oral ifetroban capsules for the treatment of cancer metastasis, cardiovascular disease, aspirin exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy. ifetrobanclinical dataatc codenoneidentifiers iupac name 3--7-oxabicyclohept-2-yl}methyl)phenyl]propanoic acid cas number143443-90-7pubchem cid23724921drugbankdb12321chemspider58452uniie833kt807kkeggd04500chemblchembl2146062comptox dashboard (epa)dtxsid40869931 chemical and physical dataformulac25h32n2o5molar mass440.540 g·mol−13d model (jsmol)interactive image smiles o=c(nccccc)c1nc(oc1)4c2o(cc2)4cc3ccccc3ccc(=o)o synthesis ifetroban synthesis: drugs future (c.f. lednicer book 6).